Peptide therapeutics Market Key Players- AstraZeneca plc., Eli Lilly and Company, Merck & Co. Inc., Novo Nordisk A/S., Teva Pharmaceutical Industries Ltd

The global peptide therapeutics market was valued at US$ 25.6 Billion in 2019, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2020-2030). Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. …